10-Q/A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_______________

FORM 10-Q/A

Amendment No. 1

____________

[X]  QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2014

[   ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT OF 1934

For the transition period from ______ to _______

Commission File Number 000-53698

TECHNOLOGY APPLICATIONS INTERNATIONAL CORPORATION

(Name of small business issuer in its charter)

Florida	27-1116025
(State of incorporation)	(I.R.S. Employer Identification No.)

18851 N.E. 29^th Avenue, Suite 700,

Adventura, Florida 33180

(Address of principal executive offices)

(786) 787-0402

(Registrant’s telephone number)

Copy of all Communications to:

Law Office of Andrew Coldicutt

1220 Rosecrans Street, PMB 258

San Diego, CA 92106

Phone: 619-228-4970

Info@ColdicuttLaw.com

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.   Yes [X]   No [   ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).   Yes [X]   No [   ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer	[   ]	Accelerated filer	[   ]
Non-accelerated filer	[   ] (Do not check if a smaller reporting company)	Smaller reporting company	[X]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes [   ]  No [X]

As of May 20, 2014, there were 118,581,119 shares of the registrant’s $0.001 par value common stock issued and outstanding.

-----------------------------------

EXPLANATORY NOTE

-----------------------------------

This Amendment No. 1 (this "Amendment") to the Quarterly Report on Form 10-Q of Technology Applications International Corporation (the "Company") for the quarter ended March 31, 2014, originally filed with the U.S. Securities and Exchange Commission (the "SEC") on May 20, 2014, (the "Original Filing"), is being filed solely to include the XBRL Exhibits.

Except as described above, this Amendment does not modify or update the disclosures presented in, or exhibits to, the Original Filing in any way.  This Amendment speaks as of the date of the Original Filing and does not reflect events occurring after the filing of the Original Filing.  Accordingly, this Amendment should be read in conjunction with the Original Filing, as well as any other filings made by the Company with the SEC pursuant to Section 13(a) or 15(d) of Securities Exchange Act of 1934, as amended, subsequent to the filing of the Original Filing.

2

ITEM 6. EXHIBITS

Exhibit
Number	Description of Exhibit		Filing
3.1	Articles of Incorporation	Filed with the SEC on January 19, 2010 as part of the Company’s Registration of Securities on Form 10-12G.
3.1(a)	Restated Articles of Incorporation	Filed with the SEC on April 18, 2011 as part of the Company’s Current Report on Form 8-K.
3.2	Bylaws	Filed with the SEC on January 19, 2010 as part of the Company’s Registration of Securities on Form 10-12G.
3.2(a)	Amended Bylaws	Filed with the SEC on April 18, 2011 as part of the Company’s Current Report on Form 8-K.
10.1	Lease between Brickell Bay Tower Ltd., Inc. and Raj Ventures, Inc. dated October 18, 2010.	Filed with the SEC on March 28, 2010 as part of the Company’s Annual Report on Form 10-K.
10.2	Share Purchase Agreement by and among Raj Ventures, Inc., Willowhuasca Wellness, Inc., and Raj Ventures Funding, Inc., dated April 12, 2010.	Filed with the SEC on April 12, 2010 as part of the Company’s Current Report on Form 8-K.
10.3	Bill of Sale and Assignment between Raj Ventures, Inc., and High Voltage Environmental Applications, Inc., dated as of August 26, 2010.	Filed with the SEC on September 1, 2010 as part of the Company’s Current Report on Form 8-K.
10.4	Promissory Note between the Company and Joe-Val, Inc., dated March 27, 2012.	Filed with the SEC on March 27, 2012 as part of the Company’s Current Report on Form 8-K.
10.5	Promissory Note between the Company and Coast To Coast Equity Group, Inc., dated June 25, 2012.	Filed with the SEC on August 20, 2012 as part of the Company’s Quarterly Report on Form 10-Q.
10.6	Convertible debenture between the Company and Shane Case, dated September 26, 2012.	Filed with the SEC on November 19, 2012 as part of the Company’s Quarterly Report on Form 10-Q.
10.7	Distribution Agreement between Regenetech, Inc. and Renuéll Int’l, Inc., dated December 29, 2011 and Amended on December 13, 2012.	Filed with the SEC on January 17, 2013 as part of the Company’s S-1/A...
10.8	Form of Subscription Agreement.	Filed with the SEC on November 29, 2012 as part of the Company’s S-1/A.
10.9	Consulting Agreement between the Company and John Stickler.	Filed with the SEC on December, 27, 2012 as part of the Company’s S-1/A
10.10	Co-License Agreement by and between Technology Applications International Corporation and the National Aeronautics and Space Administration, dated September 30, 2013.	Filed with the SEC on October 4, 2013, as part of our Current Report on Form 8-K.
16.1	Letter from Lake of Associates CPA’s LLC, dated March 12, 2013.	Filed with the SEC on March 14, 2013 as part of the Company’s Current Report on Form 8-K.
21.1	List of Subsidiaries	Filed with the SEC on April 16, 2012 as part of the Company’s Annual Report on Form 10-K.
31.01	Certification of Principal Executive Officer Pursuant to Rule 13a-14	Filed herewith.
31.02	Certification of Principal Financial Officer Pursuant to Rule 13a-14	Filed herewith.
32.01	Certification of CEO and CFO Pursuant to Section 906 of the Sarbanes-Oxley Act	Filed herewith.
101.INS*	XBRL Instance Document	Furnished herewith.
101.SCH*	XBRL Taxonomy Extension Schema Document	Furnished herewith.
101.CAL*	XBRL Taxonomy Extension Calculation Linkbase Document	Furnished herewith.
101.LAB*	XBRL Taxonomy Extension Labels Linkbase Document	Furnished herewith.
101.PRE*	XBRL Taxonomy Extension Presentation Linkbase Document	Furnished herewith.
101.DEF*	XBRL Taxonomy Extension Definition Linkbase Document	Furnished herewith.

*Pursuant to Regulation S-T, this interactive data file is deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections.

3

SIGNATURES

In accordance with Section 13 or 15(d) of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

TECHNOLOGY APPLICATIONS INTERNATIONAL CORPORATION

Dated: May 23, 2014

/s/ Charles J. Scimeca

By: Charles J. Scimeca

Its: President, Principal Executive Officer & Principal Financial Officer (Principal Accounting Officer)

Pursuant to the requirement of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Company and in the capacities and on the dates indicated:

Dated: May 23, 2014

/s/ Charles J. Scimeca

Charles J. Scimeca – Director

Dated: May 23, 2014

/s/ John Stickler

John Stickler – Director

4

EX-31.1

Exhibit 31.1 Certification   

EX-31.2

Exhibit 31.2 Certification   

EX-32.1

Exhibit 32.1 Certification   

XML

5. Capital Stock (Details) (USD $)	24 Months Ended			3 Months Ended
	Dec. 31, 2012	Dec. 31, 2013 Exercisable	Mar. 31, 2014 Outstanding	Mar. 31, 2014 Granted	Mar. 31, 2014 Expired
Number of Warrant Shares, instant		100,000	1,149,000
Number of Warrant Shares, duration	1,030,000			1,149,000	100,000
Weighted Average Exercise Price, instant		$ 1.00	$ 0
Weighted Average Exercise Price, duration				$ 1.00

XML

4. Convertible Debenture

3 Months Ended

Mar. 31, 2014

Notes to Financial Statements

4. Convertible Debenture

4. Convertible Debenture

During December 2011, the Company received $100,000 as a deposit for entering into a distribution agreement.  On March 22, 2012, the Company converted the $100,000 deposit into a convertible debenture.  The convertible debenture bears interest at a rate of five-percent (5%) per annum and is payable March 21, 2014.  At the Holder’s option, principle and unpaid accrued interest shall be convertible into common stock at a rate of $0.50 per share.  In addition to the common stock, the Holder shall receive warrants to purchase an equal number of shares of common stock exercisable at $1.00 per share.  These warrants expire at the earlier of 180 days after the common stock commences quotation on the OTC Bulletin Board or one-year from exercise. In December 2013, the Noteholder elected to convert $25,000 into 50,000 shares of the Company’s Common Stock at $0.50 per share.  In February 2014, the Noteholder elected to convert $84,143 (including accrued interest of $9,143) into 168,285 shares of the Company’s Common Stock at $0.50 per share. The Company issued 218,285 warrants to purchase 218,285 shares of common stock exercisable at $1.00 per share. As of March 31, 2013, 218,285 warrants are not exercised. Warrant expiration date is September 21, 2014 (180 days after the Company’s common stock commences quotation on the OTC Bulletin Board (March 25, 2014).

On September 25, 2012, the Company issued a $100,000 convertible debenture.  The convertible debenture bears interest at a rate of five-percent (5%) per annum and is payable September 20, 2013.  At the Holder’s option, principle and unpaid accrued interest shall be convertible into common stock at a rate of $0.50 per share.  In addition to the common stock, the Holder shall receive warrants to purchase an equal number of shares of common stock exercisable at $1.00 per share.  These warrants expire at the earlier of 180 days after the common stock commences quotation on the OTC Bulletin Board or one-year from exercise. This convertible debenture extended 360 days on September 21, 2013. In December 2013, the Noteholder elected to convert $25,000 into 50,000 shares of the Company’s Common Stock at $0.50 per share.  In February 2014, the Noteholder elected to convert $88,273 (including accrued interest of $13,273) into 176,515 shares of the Company’s Common Stock at $0.50 per share. The Company issued 226,515 warrants to purchase 226,515 shares of common stock exercisable at $1.00 per share. As of March 31, 2013, 226,515 warrants are not exercised. Warrant expiration date is September 21, 2014 (180 days after the Company’s common stock commences quotation on the OTC Bulletin Board (March 25, 2014).

On May 23, May 31, June 10, July 29, August 14, and September 25, 2013, the Company issued a $10,000, $10,000, $25,000, $4,000, $50,000 and $20,000 convertible debentures, respectively.  The convertible debentures bear interest at a rate of ten-percent (10%) per annum and is payable May 18, May 26, June 5, 2014, July 24, august 9, September 20, 2014, respectively.  At the Holder’s option, principle and unpaid accrued interest shall be convertible into common stock at a rate of $0.50 per share.  In addition to the common stock, the Holder shall receive warrants to purchase an equal number of shares of common stock exercisable at $1.00 per share.  These warrants expire at the earlier of 180 days after the common stock commences quotation on the OTC Bulletin Board or one-year from exercise. In February 2014, the Noteholder elected to convert $110,866 (including accrued interest of $6,866) into 220,785 shares of the Company’s Common Stock at $0.50 per share. The Company issued 220,785 warrants to purchase 220,785 shares of common stock exercisable at $1.00 per share. As of March 31, 2013, 220,785 warrants are not exercised. Warrant expiration date is September 21, 2014 (180 days after the Company’s common stock commences quotation on the OTC Bulletin Board (March 25, 2014). As of March31, 2014, the convertible debenture was $21,025 (including accrued interest of $1,025). In April 2014, the Noteholder elected to convert $20,767 (including accrued interest of $767) into 41,534 shares of the Company’s Common Stock at $0.50 per share. The Company issued 41,534 warrants to purchase 41,534 shares of common stock exercisable at $1.00 per share.

The following table reflects the components of the initial allocation:

Compound derivative	$ 521,452
Convertible debentures payable, net of discount	-
Interest expense	197,452
	$ 324,000

The Compound derivative comprises certain derivative features embedded in the host convertible debenture contracts including the conversion feature and warrants both of which contain anti-dilution protections.  These instruments were combined into one compound derivative and bifurcated from the host instrument at fair value.  The Company applied the Black-Scholes Merton valuation technique to fair value these derivatives because this technique embodies all of the assumptions necessary to fair value these compound derivative instruments.

Since the derivative financial instruments are required to be recorded, both initially, and subsequently, at fair value, there were insufficient proceeds to allocate any amount to the convertible debentures and, accordingly, it has no carrying value on the date of inception.  Additionally, proceeds were insufficient to record the fair values of the derivative financial instruments, resulting in initial interest expense of $197,452.  It should be noted that the derivative instruments will be adjusted to fair value at each reporting date.  As the Company does not have historical volatility data for its own stock, the expected volatility was based upon the Company’s peer group in the industry in which it does business.  Fair values are highly influenced by the trading stock price and volatility of the peer group, changes in our credit risk and market interest rates.

The company amortizes the discount on the convertible debentures resulting from the initial allocation over the term of the convertible debt instruments using the effective method.  Amortization expense arising from this method for the years ended March 31, 2014 and December 31, 2013 amounted to $66,289 and $182,197 which have been included as a component of interest expense. During the quarter ended March 31, 2014 the Company converted $254,000 of the convertible debt into 485,000 shares of the Company’s common stock. The balance of the convertible debt as of March 31, 2014 is $19,999 with a debt discount of $9,611, for net convertible debt of $10,388.

XML

7. Related Parties (Details Narrative) (USD $)	1 Months Ended
	Jun. 30, 2012	Mar. 31, 2014	Dec. 31, 2013
Related Party Transactions [Abstract]
Due to affiliates		$ 341,000	$ 237,000
Loan from affiliate	125,000
Interest rate on loan from affiliate	10.00%
Oustanding balance on loan from affiliate		$ 77,401	$ 77,401

XML

6. Derivative Liability Fair Value Adjustment (Details) (USD $)	3 Months Ended	12 Months Ended
	Mar. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Notes to Financial Statements
Derivative liability	$ 2,557,054	$ 349,940	$ 276,000
Derivative liability recorded		266,912
Fair value adjustment	1,926,797	(161,892)
Adjustment due to conversion	(87,599)	(31,080)
New warrant issued with stock	$ 367,916

XML

8. Subsequent Events (Details Narrative) (USD $)	1 Months Ended		3 Months Ended
	Apr. 30, 2014	Feb. 28, 2014	Mar. 31, 2014	Apr. 16, 2014	Apr. 03, 2014	Sep. 25, 2013	Aug. 14, 2013	Jul. 29, 2013	Jun. 10, 2013	May 31, 2013	May 23, 2013	Feb. 13, 2013	Sep. 25, 2012	Mar. 22, 2012	Oct. 28, 2011	Oct. 13, 2009
Subsequent Events [Abstract]
Common stock issued for cash, shares				20,000	5,000											3,000,000
Common stock issued for cash, value																$ 3,000
Common stock issued for cash, price per share				$ 0.50	$ 1.00							$ 1.00			$ 0.50
Warrants included in stock issuance				20,000	5,000
Shares underlying warrants in stock issuance				20,000	5,000
Exercise price of warrants in stock issuance				$ 1.00	$ 2.00	$ 1.00	$ 1.00	$ 1.00	$ 1.00	$ 1.00	$ 1.00		$ 1.00	$ 1.00
Expiration period of warrants				180 days	180 days
Warrants issued for March/April 2014 debenture		226,515
Exercise price of warrants issued for March/April 2014 debenture		$ 1.00
Amount of debt converted from debentures	$ 20,767		$ 254,000
Price per share of common stock converted from debentures	$ 0.50
Shares of common stock issued from conversion of debentures	41,534		485,000
Exercise price of warrants issued for debentures	$ 1.00
Warrants issued for debentures	41,534

XML

3. Machinery and Equipment

3 Months Ended

Mar. 31, 2014

Property, Plant and Equipment [Abstract]

3. Machinery and Equipment

3. Machinery and Equipment

Machinery and equipment are recorded at cost. Expenditures for maintenance and repairs are charged to earnings as incurred whereas additions, renewals and betterments are capitalized. When machinery and equipment are retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the respective accounts, and any gain or loss is included in operations. Depreciation of machinery and equipment is provided using the straight-line method over the assets estimated useful lives of approximately 5 to 7 years. Leasehold improvements, if any, are amortized on a straight-line basis over the term of the lease or the estimated useful lives, whichever is shorter.

Machinery and equipment, as of March 31, 2014 and December 31, 2013, consisted of the following:

	Estimated Useful Lives	March 31, 2014	December 31, 2013
Computer Equipment	3 Years	$ 4,162	$ 4,162
Machinery and equipment	5 Years	13,418	13,418
Furniture and fixtures	7 Years	14,073	14,073
Accumulated depreciation		(13,464)	(12,282)
		$ 18,189	$ 19,371

Depreciation expense for the three month periods ended March 31, 2014 and 2013 were $1,182 and $993, respectively.

XML

CONSOLIDATED BALANCE SHEETS (USD $)	Mar. 31, 2014	Dec. 31, 2013
Current assets
Cash and cash equivalents	$ 218,312	$ 4,891
Inventories	88,420	70,862
Deposits	7,000	7,000
Other current assets	1,909	1,909
Total current assets	315,641	84,662
Trademarks, net	1,914	1,940
Machinery and equipment, net	18,189	19,371
Total assets	335,744	105,973
Liabilities
Accounts payable and accrued expenses	351,465	344,415
Advances from affiliate	340,757	237,480
Loan from affiliate	77,401	77,401
Convertible debentures (net of debt discount of $9,611 and $75,902 respectively)	10,388	198,099
Derivative liability	2,557,054	349,940
Total current liabilities	3,337,065	1,207,335
Total liabilities	3,337,065	1,207,335
Shareholders' deficit
Preferred stock, par value, $0.001 per share, 50,000,000 shares authorized, none issued or outstanding	0	0
Common stock, par value $0.001 par value, 300,000,000 shares authorized, 118,514,615 and 117,348,000 shares issued and outstanding at March 31, 2014 and December 31, 2013, respectively.	118,515	117,348
Additional paid in capital	1,139,346	586,199
Subscription receivable	(66,500)	0
Accumulated deficit	(4,192,682)	(1,804,909)
Total shareholders' deficit	(3,001,321)	(1,101,362)
Total liabilities and shareholders' deficit	$ 335,744	$ 105,973

XML

1. Nature of Operations and Basis of Presentation

3 Months Ended

Mar. 31, 2014

Organization, Consolidation and Presentation of Financial Statements [Abstract]

1. Nature of Operations and Basis of Presentation

1. Nature of Operations and Basis of Presentation

Nature of Operations

Technology Applications International Corporation (formerly Raj Ventures, Inc.) (“Technology”) was incorporated on October 14, 2009 under the laws of Florida. Renuell Int’l, Inc. and NueEarth, Inc., Technology’s wholly owned subsidiaries and Technology, collectively, are referred to here-in as the “Company”, a development stage company. The Company is engaged in developing market entry technology products and services into early and mainstream technology products and services. Through our subsidiaries, we are focused on developing and manufacturing a line of technologically advanced skin care products and providing environmental management solutions that use electron particle accelerator technology.

Principles of Consolidation

The consolidated financial statements include the accounts of Technology Applications International Corporation and its wholly owned subsidiaries, Renuell Int’l, Inc. and NueEarth, Inc. All significant inter-company accounts and transactions have been eliminated in consolidation.

Basis of Presentation and Going Concern Considerations

The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2014 are not necessarily indicative of the results that may be expected for the full year ending December 31, 2014.

For further information, refer to the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013.

The accompanying financial statements have been presented on the basis that it is a going concern which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has not yet established an ongoing source of revenues sufficient to cover its operating costs. The Company’s ability to continue as a going concern is highly dependent upon management’s ability to increase near-term operating cash flows and obtain additional working capital through the issuance of debt and or equity. If the Company is unable to obtain adequate capital, it could be forced to cease operations.

These consolidated financial statements present the financial condition, and results of operations and cash flows of the operating companies.

Development Stage Risk

Since its inception, the Company has been dependent upon the receipt of capital investment to fund its operating activities. In addition to the normal risks associated with a new business venture, there can be no assurance that the Company’s business plans will be successfully executed. The Company’s ability to execute its business plans is dependent on its ability to obtain additional debt and equity financing and achieving a profitable level of operations. There can be no assurance that sufficient financing will be obtained or that we will achieve a profitable level of operations.

The Company has minimal revenues generated from operations due to the sale of sample products. Accordingly, the Company’s activities have been accounted for as those of a “Development Stage Enterprise” as set forth in Accounting Standards Codification (“ASC”) 915 “Development Stage Entities”. Among the disclosures required are that the Company’s financial statements be identified as those of a development stage company and that the statements of operations, shareholders’ equity / (deficit) and cash flows disclose activity since the date of the Company’s inception.

XML

3. Machinery and Equipment (Details Narrative) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 1,182	$ 993

XML

4. Convertible Debenture (Details Narrative) (USD $)	1 Months Ended				3 Months Ended		12 Months Ended	53 Months Ended
	Apr. 30, 2014	Feb. 28, 2014	Dec. 31, 2013	Dec. 31, 2011	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013	Mar. 31, 2014	Apr. 16, 2014	Apr. 03, 2014	Sep. 25, 2013	Aug. 14, 2013	Jul. 29, 2013	Jun. 10, 2013	May 31, 2013	May 23, 2013	Feb. 13, 2013	Sep. 25, 2012	Mar. 22, 2012	Oct. 28, 2011
Notes to Financial Statements
Deposit on distribution agreeement				$ 100,000
Deposit converted into convertible debenture																			100,000
Convertible debenture issued											20,000	50,000	4,000	25,000	10,000	10,000		100,000
Interest rate of convertible debenture, per annum											10.00%	10.00%	10.00%	10.00%	10.00%	10.00%		5.00%	5.00%
Maturity date of convertible debenture											Sep. 20, 2014	Aug. 09, 2014	Jul. 24, 2014	Jun. 05, 2014	May 26, 2014	May 18, 2014		Sep. 20, 2013	Mar. 21, 2014
Debt conversion to common stock rate											$ 0.50	$ 0.50	$ 0.50	$ 0.50	$ 0.50	$ 0.50		$ 0.50	$ 0.50
Number of warrants offered per share issued from converted debt											1	1	1	1	1	1		1	1
Warrants exercisable for common stock, price per share									$ 1.00	$ 2.00	$ 1.00	$ 1.00	$ 1.00	$ 1.00	$ 1.00	$ 1.00		$ 1.00	$ 1.00
Expiration of warrants, years											1 year	1 year	1 year	1 year	1 year	1 year	1 year	1 year	1 year	1 year
Expiration of warrants, days after common stock is quoted on OTCBB											180 days	180 days	180 days	180 days	180 days	180 days	180 days	180 days	180 days	180 days
Initial Interest expense							197,452
Amortization expense					66,289	24,658	182,197	512,839
Amount of debt converted from debentures	20,767				254,000
Shares of common stock issued from conversion of debentures	41,534				485,000
Amount of convertible debentures still outstanding					19,999			19,999
Debt discount on convertible debt					9,611			9,611
Net convertible debt					10,388			10,388
Amount of debt converted from 2013 debentures	20,767	110,866
Shares of common stock issued from conversion of 2013 debentures	41,543	220,785
Price per share of common stock converted from 2013 debentures	$ 0.50	$ 0.50
Warrants issued for 2013 debentures	41,534	220,785
Exercise price of warrants issued for 2013 debentures	$ 1.00	$ 1.00
Expiration period of warrants issued for 2013 debentures		Sep. 21, 2014
Warrants outstanding of the 2013 debenture warrants					220,785			220,785
Amount of 2013 convertible debentures still outstanding					21,025			21,025
Amount of debt converted from December 2011 debenture		84,143	25,000
Shares of common stock issued from conversion of December 2011 debenture		168,285	50,000
Price per share of common stock converted from December 2011 debenture			$ 0.50
Amount of debt converted from September 2012 debenture		$ 88,273	$ 25,000
Shares of common stock issued from conversion of September 2012 debenture		176,515	50,000
Price per share of common stock converted from September 2012 debenture		$ 0.50	$ 0.50
Warrants issued for December 2011 debenture		218,285
Exercise price of warrants issued for December 2011 debenture		$ 1.00
Expiration date of warrants issued for December 2011 debenture		Sep. 21, 2014
Warrants outstanding of the December 2011 debenture warrants					218,285			218,285
Warrants issued for September 2012 debenture		226,515
Exercise price of warrants issued for September 2012 debenture		$ 1.00
Expiration date of warrants issued for September 2012 debenture		Sep. 21, 2014
Warrants outstanding of the September 2012 debenture warrants					226,515			226,515

XML

2. Inventories

3 Months Ended

Mar. 31, 2014

Inventory Disclosure [Abstract]

2. Inventories

2. Inventories

Inventories are stated at the lower of cost or market value. The Company reduces the value of its inventories to market value when the value is believed to be less than the cost of the item.

	March 31, 2014	December 31, 2013
Raw materials	$ -	$ -
Work-in-process	-	-
Finished goods	88,420	70,862
Total Inventories	$ 88,420	$ 70,862

No reserves for inventory have been deemed necessary at March 31, 2014.

XML

CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Mar. 31, 2014	Dec. 31, 2013
Statement of Financial Position [Abstract]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	50,000,000	50,000,000
Preferred stock, shares issued	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	300,000,000	300,000,000
Common stock, shares issued	118,514,615	117,348,000
Common stock, shares outstanding	118,514,615	117,348,000
Discount on convertible debentures	$ 9,611	$ 75,902

XML

4. Convertible Debenture (Tables)

3 Months Ended

Mar. 31, 2014

Notes to Financial Statements

Fair value of the warrants granted utilizing

Compound derivative	$ 521,452
Convertible debentures payable, net of discount	-
Interest expense	197,452
	$ 324,000

XML

Document and Entity Information	3 Months Ended
	Mar. 31, 2014	May 20, 2014
Document And Entity Information
Entity Registrant Name	Technology Applications International Corp
Entity Central Index Key	0001481427
Document Type	10-Q
Document Period End Date	Mar. 31, 2014
Amendment Flag	true
Current Fiscal Year End Date	--12-31
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		118,581,119
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2014
Amendment Description	Amendment #1

XML

5. Capital Stock (Tables)

3 Months Ended

Mar. 31, 2014

Notes to Financial Statements

Warrant Activity

	Shares	Weighted-Average Exercise Price Per Share
Exercisable at December 31, 2013	100,000	1.00
Granted	1,149,000	1.00
Expired	100,000
Outstanding, March 31, 2014	1,149,000	1.00

XML

CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended		53 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014
Income Statement [Abstract]
Revenues	$ 2,268	$ 10,047	$ 63,306
Cost of revenues	2,920	5,449	34,219
Gross profit	(652)	4,598	29,087
Expenses
General and administrative	128,728	138,658	1,621,222
Loss From Operation	(129,380)	(134,060)	(1,592,135)
Other income (expense)
Gain (loss) on derivative valuation	(1,926,797)	(25,000)	(1,785,365)
Gain on forgiveness of debts	0	0	1,000
Derivative expense	(251,814)	0	(251,814)
Interest expense	(79,782)	(29,374)	(564,368)
Total other income (expense)	(2,258,393)	(54,374)	(2,600,547)
Net loss	$ (2,387,773)	$ (188,434)	$ (4,192,682)
Loss per share
Basic and diluted	$ (0.02)	$ 0.0
Weighted average number of shares
Basic and diluted	117,742,089	117,248,000

XML

7. Related Parties

3 Months Ended

Mar. 31, 2014

Related Party Transactions [Abstract]

7. Related Parties

7. Related Parties

An affiliate of the Company, an entity owned by the Company’s president, has been funding operations of the Company by making payments directly to third parties or advancing monies to the Company. These amounts bear no interest and are payable on demand. Amounts due to the affiliate at March 31, 2014 and December 31, 2013 are approximately 341,000 and $237,000, respectively.

During June 2012, the Company borrowed $125,000 from an affiliate. The loan bears interest at 10% per annum and is unsecured and payable upon demand. The Company has paid $36,120 towards the loan amount. The outstanding balance at March 31, 2014 and December 31, 2013 is $77,401.

XML

6. Fair Value Measurements

3 Months Ended

Mar. 31, 2014

Notes to Financial Statements

6. Fair Value Measurements

6. Fair Value Measurements

On a recurring basis, we measure certain financial assets and liabilities based upon the fair value hierarchy.  The following table presents information about the Company’s liabilities measured at fair value as of March 31, 2014 and December 31, 2013:

	Level 1	Level 2	Level 3	Fair Value at March 31, 2014
Liabilities
Derivative Liability	-	-	$ 2,557,054	$ 2,557,054

	Level 1	Level 2	Level 3	Fair Value at December 31, 2013
Liabilities
Derivative Liability	-	-	$ 349,940	$ 349,940

The fair value changes in the fair value of recurring fair value measurements using significant unobservable inputs (Level 3), relate solely to the derivative liability as follows:

Balance as of December 31, 2012	$ 276,000
Derivative liability recorded	266,912
Adjustment due to conversion	(31,080)
Fair value adjustment	(161892)
Balance at December 31, 2013	349,940
Adjustment due to conversion	(87,599)
New warrant issued with stock	367,916
Fair value adjustment	1,926,797
Balance at March 31, 2014	2,557,054

XML

4. Convertible Debenture (Details) (USD $)	3 Months Ended		12 Months Ended	53 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013	Mar. 31, 2014
Notes to Financial Statements
Compound derivative	$ 251,814	$ 0	$ 521,452	$ 251,814
Convertible debentures payable, net of discount			0
Interest expense			197,452
Total convertible debentures			$ 324,000

XML

6. Fair Value Measurements (Tables)

3 Months Ended

Mar. 31, 2014

Notes to Financial Statements

Derivative Liabilities

	Level 1	Level 2	Level 3	Fair Value at March 31, 2014
Liabilities
Derivative Liability	-	-	$ 2,557,054	$ 2,557,054

	Level 1	Level 2	Level 3	Fair Value at December 31, 2013
Liabilities
Derivative Liability	-	-	$ 349,940	$ 349,940

Derivative Liability Fair Value Adjustment

Balance as of December 31, 2012	$ 276,000
Derivative liability recorded	266,912
Adjustment due to conversion	(31,080)
Fair value adjustment	(161892)
Balance at December 31, 2013	349,940
Adjustment due to conversion	(87,599)
New warrant issued with stock	367,916
Fair value adjustment	1,926,797
Balance at March 31, 2014	2,557,054

XML

2. Inventories (Tables)

3 Months Ended

Mar. 31, 2014

Inventory Disclosure [Abstract]

Inventories

	March 31, 2014	December 31 2013
Raw materials	$ -	$ -
Work-in-process	-	-
Finished goods	88,420	70,862
Total Inventories	$ 88,420	$ 70,862

XML

8. Subsequent Events

3 Months Ended

Mar. 31, 2014

Subsequent Events [Abstract]

8. Subsequent Events

8. Subsequent Events

Pursuant to Accounting Standards Codification 855-10, the Company has evaluated all events or transactions that have occurred from January 1, 2014 through the filing with the SEC. The Company did not have any material recognizable subsequent events during this period.

On April 2014, the Noteholder elected to convert $20,767 (including accrued interest of $767) into 41,534 shares of the Company’s Common Stock at $0.50 per share. The Company issued 41,534 warrants to purchase 41,534 shares of common stock exercisable at $1.00 per share.

On April 3, 2014, the Company entered stock subscription agreement of 5,000 shares at $1.00 per share with 5,000 warrants to purchase 5,000 shares of common stock with an exercise price of $2.00 per share. These warrants expire 180 days after stock issuance date.

On April 16, 2014, the Company entered stock subscription agreement of 20,000 shares at $0.50 per share with 20,000 warrants to purchase 20,000 shares of common stock with an exercise price of $1.00 per share. These warrants expire 180 days after stock issuance date.

XML

1. Nature of Operations and Summary of Significant Accounting Policies (Policies)

3 Months Ended

Mar. 31, 2014

Policy Text Block [Abstract]

Nature of Operations

Nature of Operations

Technology Applications International Corporation (formerly Raj Ventures, Inc.) (“Technology”) was incorporated on October 14, 2009 under the laws of Florida. Renuell Int’l, Inc. and NueEarth, Inc., Technology’s wholly owned subsidiaries and Technology, collectively, are referred to here-in as the “Company”, a development stage company. The Company is engaged in developing market entry technology products and services into early and mainstream technology products and services. Through our subsidiaries, we are focused on developing and manufacturing a line of technologically advanced skin care products and providing environmental management solutions that use electron particle accelerator technology.

Principles of Consolidation

Principles of Consolidation

The consolidated financial statements include the accounts of Technology Applications International Corporation and its wholly owned subsidiaries, Renuell Int’l, Inc. and NueEarth, Inc. All significant inter-company accounts and transactions have been eliminated in consolidation.

Basis of Presentation and Going Concern Considerations

Basis of Presentation and Going Concern Considerations

The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2014 are not necessarily indicative of the results that may be expected for the full year ending December 31, 2014.

For further information, refer to the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013.

The accompanying financial statements have been presented on the basis that it is a going concern which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has not yet established an ongoing source of revenues sufficient to cover its operating costs. The Company’s ability to continue as a going concern is highly dependent upon management’s ability to increase near-term operating cash flows and obtain additional working capital through the issuance of debt and or equity. If the Company is unable to obtain adequate capital, it could be forced to cease operations.

These consolidated financial statements present the financial condition, and results of operations and cash flows of the operating companies.

Development Stage Risk

Development Stage Risk

Since its inception, the Company has been dependent upon the receipt of capital investment to fund its operating activities. In addition to the normal risks associated with a new business venture, there can be no assurance that the Company’s business plans will be successfully executed. The Company’s ability to execute its business plans is dependent on its ability to obtain additional debt and equity financing and achieving a profitable level of operations. There can be no assurance that sufficient financing will be obtained or that we will achieve a profitable level of operations.

The Company has minimal revenues generated from operations due to the sale of sample products. Accordingly, the Company’s activities have been accounted for as those of a “Development Stage Enterprise” as set forth in Accounting Standards Codification (“ASC”) 915 “Development Stage Entities”. Among the disclosures required are that the Company’s financial statements be identified as those of a development stage company and that the statements of operations, shareholders’ equity / (deficit) and cash flows disclose activity since the date of the Company’s inception.

XML

3. Machinery and Equipment (Tables)

3 Months Ended

Mar. 31, 2014

Property, Plant and Equipment [Abstract]

Machinery and equipment

	Estimated Useful Lives	March 31, 2014	December 31, 2013
Computer Equipment	3 Years	$ 4,162	$ 4,162
Machinery and equipment	5 Years	13,418	13,418
Furniture and fixtures	7 Years	14,073	14,073
Accumulated depreciation		(13,464)	(12,282)
		$ 18,189	$ 19,371

XML

3. Machinery and Equipment (Details) (USD $)			12 Months Ended
	Mar. 31, 2014	Dec. 31, 2013	Dec. 31, 2013 Computer Equipment	Dec. 31, 2013 Machinery and Equipment	Dec. 31, 2013 Furniture and Fixtures
Computer Equipment	$ 4,162	$ 4,162
Machinery and equipment	13,418	13,418
Furniture and fixtures	14,073	14,073
Accumulated depreciation	(13,464)	(12,282)
Machinery and equipment, net	$ 18,189	$ 19,371
Estimated useful lives			3 years	5 years	7 years

XML

5. Capital Stock (Details Narrative) (USD $)	1 Months Ended			2 Months Ended		24 Months Ended
	Mar. 31, 2014	Feb. 28, 2014	Dec. 31, 2013 Units	Feb. 29, 2012	Dec. 31, 2011	Dec. 31, 2012	Apr. 16, 2014	Apr. 03, 2014	Sep. 25, 2013	Aug. 14, 2013	Jul. 29, 2013	Jun. 10, 2013	May 31, 2013	May 23, 2013	Feb. 13, 2013	Sep. 25, 2012	Mar. 22, 2012	Nov. 08, 2011	Oct. 28, 2011	Oct. 20, 2011	Aug. 26, 2010	Oct. 13, 2009
Notes to Financial Statements
Common stock issued for cash, shares							20,000	5,000														3,000,000
Common stock issued for cash, value																						$ 3,000
Common stock issued for cash, shares, duration	485,000			794,000	236,000
Common stock issued for cash, value, duration	234,000			397,000	118,000
Common stock issued for equipment, shares																					100,000
Common stock issued for debt, shares																				101,800,000
Common stock issued for services, shares																		5,591,000	5,727,000
Private placement units offered															3,000,000				10000
Shares per unit															1				1,000
Common stock price per share							$ 0.50	$ 1.00							$ 1.00				$ 0.50
Warrants per unit															1				1
Class A Warrants, shares per warrant															1				1,000
Exercise price per share in warrant															$ 1.50				$ 1.00
Expiration of warrants, years									1 year	1 year	1 year	1 year	1 year	1 year	1 year	1 year	1 year		1 year
Expiration of warrants, days after common stock is quoted on OTCBB									180 days	180 days	180 days	180 days	180 days	180 days	180 days	180 days	180 days		180 days
Number of untis sold in February 13, 2013 private offering			0
Number of warrant shares issued, shares						1,030,000
Number of warrant shares expired, shares			1,030,000
Common stock issued for debt, shares, duration		565,615	100,000
Common stock issued for debt, amount, duration		254,000	50,000
Common stock issued for debt, price per share		$ 0.50	$ 0.50
Common stock issued for cash, price per share	$ 0.50
Warrants issued for debenture conversion	485,000
Exercise price of warrants issued for debenture conversion	$ 1.00
Subscription receivable	66,500
Shares issued for subscription receivable	133,000
Warrants issued for stock purchase	133,000
Exercise price of warrants issued for stock purchase	$ 1.00
Valuation of warrants issued	367,916
Amount of initial warrant valuation that exceeded the proceeds of the common sotck and were expenses to derivative expense	$ 251,814

XML

CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	3 Months Ended		53 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014
Cash flows from operating activities
Net loss	$ (2,387,773)	$ (188,434)	$ (4,192,682)
Adjustments to reconcile net income to net cash used in operating activities:
Loss (Gain) on derivative valuation	1,926,797	25,000	1,785,365
Derivative expense	251,814	0	251,814
Gain on forgiveness of debts	0	0	(1,000)
Amortization of discount on convertible debentures	66,289	24,658	512,839
Depreciation and amortization	1,208	1,020	13,720
Shares issued for services rendered	0	0	11,318
Change in current assets and current liabilities:
Accounts receivable	0	(307)	0
Inventory	(17,558)	3,139	(88,420)
Deposits	0	(10,000)	(7,000)
Other current assets	0	1,852	(1,909)
Accounts payable and accrued expenses	35,367	30,928	380,782
Other current liabilities	0	12,000	0
Net cash used in operating activities	(123,856)	(100,144)	(1,335,173)
Cash flows from investing activities
Purchase of equipment	0	0	(31,553)
Increase in trademarks	0	0	(2,170)
Net cash used in investing activities	0	0	(33,723)
Cash flows from financing activities
Proceeds from short-term advance	0	0	0
Advances from (to) affiliate, net	114,058	(7,819)	505,669
Proceeds from loan from affiliate	0	0	125,000
Repayment of loan from affiliate	(10,781)	0	(110,711)
Proceeds from issuance of convertible debenture	0	0	324,000
Proceeds from issuance of common stock	234,000	0	743,250
Net cash provided by (used in) financing activities	337,277	(7,819)	1,587,208
Net change in cash and cash equivalents	213,421	(107,963)	218,312
Cash and cash equivalents, beginning balance	4,891	120,697	0
Cash and cash equivalents, ending balance	218,312	12,734	218,312
Supplemental disclosure of cash flow information
Income taxes paid	0	0	0
Interest paid	0	0	0
Non-cash transactions affecting Operating, Investing and Financing activities
Deposit converted to convertible debenture	0	0	100,000
Issuance of common stock - shareholder note payable	0	0	101,800
Issuance of common stock for services	0	0	11,318
Issuance of common stock for convertible notes converted	486,983	0	486,983
Subscription receivable	$ 66,500	$ 0	$ 66,500

XML

5. Capital Stock

3 Months Ended

Mar. 31, 2014

Notes to Financial Statements

5. Capital Stock

5. Capital Stock

On October 14, 2009, the Company issued 3,000,000 shares of common stock for $3,000.

On August 26, 2010, the Company issued 100,000 shares of its common stock to purchase equipment.

On October 20, 2011, the Company issued 101,800,000 shares of its common stock as payment for cancellation of debt for part of the amount due to its related party.

On October 28, 2011, the Company issued 5,727,000 shares of its common stock to a consultant as payment for services rendered.

On November 8, 2011, the Company issued 5,591,000 shares of its common stock to a consultant as payment for services rendered.

During November and December 2011, the Company issued 236,000 shares of its common stock through a private placement to several investors for total cash consideration of $118,000.

During January and February 2012, the Company issued 794,000 shares of its common stock through a private placement for total cash consideration of $397,000.

In December 31, 2013, the Company issued 100,000 shares of its common stock at $0.50 for conversion of convertible debenture of $50,000.

In February 2014, the Company issued 565,615 shares of its common stock at $0.50 for conversion of convertible debenture of $254,000.

In March 2014, the Company issued 485,000 shares of its common stock at $0.50 through a private placement for total cash consideration of $234,000. Also, the Company issued 485,000 warrants to purchase 485,000 shares of common stock exercisable at $1.00 per share.

In March 2014, the Company entered into stock subscription agreement of 133,000 shares at $0.50 per share. The Company recorded $66,500 as subscription receivable. The Company issued 133,000 warrants to purchase to purchase 133,000 shares of common stock exercisable at $1.00 per share.

Due to a ratchet provision, the warrants issued during the period were accounted for as a derivative and fair valued using the Black Scholes valuation model. The initial valuation was $367,916 including $251,814 of amounts that exceeded the proceeds of the common stock and were therefore expensed immediately to derivative expense.

Stock Purchase Warrants

In conjunction with the Private Placement Memorandum dated October 28, 2011, the Company is offering up to 10,000 Units.  Each Unit consists of 1,000 shares of common stock priced at $0.50 per share and one Class A Warrant to purchase 1,000 shares of common stock with an exercise price of $1.00 per share.  These warrants expire on the earlier of (i) 180 days after the common stock commences quotation on the OTC Bulletin Board or (ii) one year after the date of issuance.

Warrants to purchase up to1,030,000 shares of common stock were issued in accordance with the Private Placement Memorandum stated above.  Of these issuances, warrants to purchase up to 236,000 shares and 794,000 shares of common stock expired during 2012 and 2013.  

In conjunction with the Private Placement Memorandum dated February 13, 2013, the Company is offering up to 3,000,000 units.  Each unit consists of 1 share of common stock priced at $1.00 and one Class A Warrant to purchase 1 share of common stock with an exercise price of $1.50 per share.  These warrants expire on the earlier of (i) 180 days after the common stock commences quotation on the OTC Bulletin Board or (ii) one year after the date of issuance. No issuances have been sold from this offering as of December 31, 2013.

In December 2013, the Noteholder elected to convert $50,000 into 100,000 shares of the Company’s Common Stock at $0.50 per share.  The Company issued 100,000 warrants to purchase 100,000 shares of common stock exercisable at $1.00 per share.  

The following table summarizes all warrant activity for the period ended March 31, 2014 and December 31, 2013:

	Shares	Weighted-Average Exercise Price Per Share
Exercisable at December 31, 2013	100,000	1.00
Granted	1,149,000	1.00
Expired	100,000
Outstanding, March 31, 2014	1,149,000	1.00

XML

6. Derivative Liabilities (Details) (USD $)	Mar. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Derivative liability	$ 2,557,054	$ 349,940	$ 276,000
Level 1
Derivative liability	0	0
Level 2
Derivative liability	0	0
Level 3
Derivative liability	2,557,054	349,940
Fair Value
Derivative liability	$ 2,557,054	$ 349,940

XML

2. Inventories (Details) (USD $)	Mar. 31, 2014	Dec. 31, 2013
Inventory Disclosure [Abstract]
Raw materials	$ 0	$ 0
Work-in-process	0	0
Finished goods	88,420	70,862
Total Inventories	$ 88,420	$ 70,862